Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lasers, Solid-State | 5 | 2020 | 164 | 1.970 |
Why?
|
Vitreous Body | 9 | 2020 | 389 | 1.680 |
Why?
|
Vitrectomy | 10 | 2020 | 358 | 1.490 |
Why?
|
Retinal Detachment | 7 | 2018 | 408 | 1.450 |
Why?
|
Eye Diseases | 4 | 2020 | 670 | 1.440 |
Why?
|
Eye Infections, Bacterial | 6 | 2021 | 236 | 1.170 |
Why?
|
Endophthalmitis | 7 | 2021 | 264 | 1.070 |
Why?
|
Laser Therapy | 5 | 2020 | 1065 | 1.040 |
Why?
|
Retinal Perforations | 4 | 2017 | 128 | 1.020 |
Why?
|
Angiogenesis Inhibitors | 12 | 2021 | 2037 | 0.970 |
Why?
|
Visual Acuity | 21 | 2020 | 2517 | 0.930 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 5 | 2016 | 664 | 0.750 |
Why?
|
Intravitreal Injections | 12 | 2021 | 345 | 0.730 |
Why?
|
Diabetic Retinopathy | 3 | 2016 | 1203 | 0.640 |
Why?
|
Scleral Buckling | 4 | 2016 | 84 | 0.630 |
Why?
|
Vitreoretinal Surgery | 1 | 2017 | 27 | 0.610 |
Why?
|
Macula Lutea | 2 | 2016 | 151 | 0.610 |
Why?
|
Timolol | 2 | 2020 | 52 | 0.600 |
Why?
|
Endotamponade | 3 | 2017 | 35 | 0.600 |
Why?
|
Ophthalmologic Surgical Procedures | 2 | 2018 | 343 | 0.580 |
Why?
|
Macular Edema | 4 | 2020 | 359 | 0.580 |
Why?
|
Ophthalmology | 1 | 2022 | 504 | 0.550 |
Why?
|
Retinal Diseases | 5 | 2021 | 687 | 0.540 |
Why?
|
Recombinant Fusion Proteins | 5 | 2016 | 3770 | 0.520 |
Why?
|
Retinal Neoplasms | 1 | 2015 | 143 | 0.470 |
Why?
|
Wet Macular Degeneration | 4 | 2020 | 146 | 0.460 |
Why?
|
Sulfur Hexafluoride | 2 | 2013 | 24 | 0.450 |
Why?
|
Retinoblastoma | 1 | 2015 | 317 | 0.440 |
Why?
|
Thiophenes | 2 | 2020 | 589 | 0.430 |
Why?
|
Ophthalmic Solutions | 2 | 2020 | 312 | 0.420 |
Why?
|
Vascular Endothelial Growth Factor A | 8 | 2021 | 3504 | 0.390 |
Why?
|
Dacryocystitis | 1 | 2011 | 67 | 0.380 |
Why?
|
Uveal Neoplasms | 3 | 2009 | 310 | 0.340 |
Why?
|
Eyelid Diseases | 1 | 2011 | 154 | 0.340 |
Why?
|
Foreign-Body Migration | 1 | 2011 | 222 | 0.340 |
Why?
|
Silicone Oils | 1 | 2008 | 22 | 0.320 |
Why?
|
Chorioretinitis | 1 | 2008 | 43 | 0.320 |
Why?
|
Sulfonamides | 2 | 2020 | 1934 | 0.300 |
Why?
|
Sickness Impact Profile | 2 | 2020 | 305 | 0.300 |
Why?
|
Eye Infections, Fungal | 1 | 2008 | 110 | 0.290 |
Why?
|
Fibrinolysin | 2 | 2016 | 132 | 0.270 |
Why?
|
Uvea | 1 | 2005 | 31 | 0.270 |
Why?
|
Pigment Epithelium of Eye | 1 | 2006 | 231 | 0.270 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2010 | 545 | 0.270 |
Why?
|
Candidiasis | 1 | 2008 | 365 | 0.260 |
Why?
|
Optic Nerve Diseases | 2 | 2021 | 326 | 0.260 |
Why?
|
Choroidal Neovascularization | 3 | 2020 | 343 | 0.250 |
Why?
|
Tomography, Optical Coherence | 10 | 2021 | 2623 | 0.240 |
Why?
|
Gases | 2 | 2017 | 192 | 0.240 |
Why?
|
Prostheses and Implants | 1 | 2011 | 1383 | 0.230 |
Why?
|
Intraocular Pressure | 4 | 2020 | 1261 | 0.220 |
Why?
|
Internet | 1 | 2014 | 3048 | 0.210 |
Why?
|
Drug Substitution | 2 | 2016 | 283 | 0.210 |
Why?
|
Vitreous Detachment | 2 | 2021 | 22 | 0.200 |
Why?
|
Retinal Hemorrhage | 1 | 2021 | 96 | 0.190 |
Why?
|
Investments | 1 | 2022 | 143 | 0.190 |
Why?
|
Macular Degeneration | 4 | 2011 | 981 | 0.190 |
Why?
|
Ultraviolet Rays | 1 | 2005 | 1059 | 0.190 |
Why?
|
Cryosurgery | 2 | 2016 | 451 | 0.180 |
Why?
|
Fundus Oculi | 3 | 2016 | 473 | 0.170 |
Why?
|
Aqueous Humor | 3 | 2017 | 163 | 0.170 |
Why?
|
Syringes | 1 | 2018 | 54 | 0.170 |
Why?
|
Exudates and Transudates | 4 | 2020 | 170 | 0.160 |
Why?
|
Epiretinal Membrane | 1 | 2018 | 69 | 0.160 |
Why?
|
Fovea Centralis | 1 | 2018 | 119 | 0.160 |
Why?
|
Fluorescein Angiography | 5 | 2021 | 939 | 0.150 |
Why?
|
Telemedicine | 1 | 2014 | 2844 | 0.150 |
Why?
|
Follow-Up Studies | 10 | 2021 | 38942 | 0.140 |
Why?
|
Melanoma | 4 | 2010 | 5446 | 0.140 |
Why?
|
Observation | 1 | 2018 | 312 | 0.140 |
Why?
|
Humans | 44 | 2022 | 739398 | 0.140 |
Why?
|
Visual Prosthesis | 1 | 2016 | 52 | 0.140 |
Why?
|
Injections, Intraocular | 1 | 2015 | 30 | 0.140 |
Why?
|
Injections, Intra-Arterial | 1 | 2015 | 193 | 0.130 |
Why?
|
Cat-Scratch Disease | 1 | 2015 | 23 | 0.130 |
Why?
|
Sertraline | 1 | 2016 | 206 | 0.130 |
Why?
|
Patient Selection | 2 | 2018 | 4211 | 0.130 |
Why?
|
Disease Transmission, Infectious | 1 | 2021 | 554 | 0.130 |
Why?
|
Patient Positioning | 1 | 2017 | 322 | 0.120 |
Why?
|
Angioid Streaks | 1 | 2013 | 12 | 0.120 |
Why?
|
Pseudoxanthoma Elasticum | 1 | 2013 | 12 | 0.120 |
Why?
|
Retrospective Studies | 18 | 2021 | 76631 | 0.120 |
Why?
|
Vitelliform Macular Dystrophy | 1 | 2013 | 12 | 0.120 |
Why?
|
Laser Coagulation | 1 | 2016 | 326 | 0.120 |
Why?
|
Subretinal Fluid | 1 | 2013 | 24 | 0.110 |
Why?
|
Peptide Fragments | 2 | 2016 | 5076 | 0.110 |
Why?
|
Antibodies, Monoclonal | 2 | 2010 | 9259 | 0.110 |
Why?
|
Treatment Outcome | 11 | 2020 | 62693 | 0.110 |
Why?
|
Retinal Vein Occlusion | 1 | 2014 | 137 | 0.110 |
Why?
|
Treatment Failure | 2 | 2016 | 2614 | 0.110 |
Why?
|
Aged, 80 and over | 13 | 2020 | 57650 | 0.110 |
Why?
|
Geographic Atrophy | 1 | 2013 | 66 | 0.110 |
Why?
|
Blindness | 1 | 2016 | 613 | 0.110 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13635 | 0.110 |
Why?
|
Cataract Extraction | 1 | 2016 | 482 | 0.110 |
Why?
|
Bacteria | 3 | 2018 | 2106 | 0.100 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2014 | 247 | 0.100 |
Why?
|
Middle Aged | 20 | 2021 | 212863 | 0.100 |
Why?
|
Drug Combinations | 2 | 2020 | 1959 | 0.100 |
Why?
|
Photography | 1 | 2014 | 518 | 0.100 |
Why?
|
Ceftazidime | 1 | 2011 | 67 | 0.100 |
Why?
|
Aged | 19 | 2020 | 162698 | 0.100 |
Why?
|
Tobramycin | 1 | 2011 | 69 | 0.100 |
Why?
|
Electroretinography | 1 | 2013 | 511 | 0.100 |
Why?
|
Ocular Hypotension | 1 | 2011 | 22 | 0.100 |
Why?
|
Medical Records | 1 | 2016 | 1413 | 0.100 |
Why?
|
Female | 25 | 2020 | 378853 | 0.090 |
Why?
|
Anterior Chamber | 1 | 2011 | 195 | 0.090 |
Why?
|
Retina | 3 | 2016 | 2633 | 0.090 |
Why?
|
Retinal Necrosis Syndrome, Acute | 1 | 2010 | 23 | 0.090 |
Why?
|
Welding | 1 | 2010 | 89 | 0.090 |
Why?
|
Diplopia | 1 | 2011 | 194 | 0.090 |
Why?
|
Male | 24 | 2020 | 349022 | 0.090 |
Why?
|
Choroid Neoplasms | 1 | 2010 | 175 | 0.090 |
Why?
|
Eye Infections, Viral | 1 | 2010 | 59 | 0.090 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2011 | 231 | 0.090 |
Why?
|
Iris Neoplasms | 1 | 2009 | 13 | 0.090 |
Why?
|
Eye Color | 2 | 2006 | 39 | 0.080 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 2009 | 63 | 0.080 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2011 | 341 | 0.080 |
Why?
|
Nevus, Pigmented | 1 | 2010 | 218 | 0.080 |
Why?
|
Herpesviridae Infections | 1 | 2010 | 276 | 0.080 |
Why?
|
Eye Injuries | 1 | 2011 | 241 | 0.080 |
Why?
|
Cost Savings | 1 | 2013 | 925 | 0.080 |
Why?
|
Vancomycin | 1 | 2011 | 500 | 0.080 |
Why?
|
Adult | 12 | 2020 | 213394 | 0.080 |
Why?
|
Philadelphia | 1 | 2008 | 262 | 0.080 |
Why?
|
Injections | 2 | 2010 | 837 | 0.080 |
Why?
|
Candida | 1 | 2008 | 171 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2018 | 2220 | 0.070 |
Why?
|
Anti-Bacterial Agents | 2 | 2017 | 7136 | 0.070 |
Why?
|
Vision Disorders | 1 | 2013 | 1058 | 0.070 |
Why?
|
Sex Distribution | 1 | 2011 | 2296 | 0.070 |
Why?
|
Device Removal | 1 | 2011 | 648 | 0.070 |
Why?
|
Morbidity | 1 | 2011 | 1763 | 0.070 |
Why?
|
Reoperation | 2 | 2016 | 4192 | 0.070 |
Why?
|
Catheterization | 1 | 2011 | 1466 | 0.070 |
Why?
|
Hair Color | 1 | 2006 | 136 | 0.070 |
Why?
|
Fibrinolytic Agents | 1 | 2015 | 2149 | 0.070 |
Why?
|
Acute Disease | 2 | 2017 | 7128 | 0.060 |
Why?
|
India | 1 | 2011 | 2189 | 0.060 |
Why?
|
Optic Disk | 2 | 2021 | 402 | 0.060 |
Why?
|
Antidepressive Agents | 1 | 2016 | 2836 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10945 | 0.060 |
Why?
|
Drug Resistance, Bacterial | 1 | 2011 | 1031 | 0.060 |
Why?
|
Skin Pigmentation | 1 | 2006 | 281 | 0.060 |
Why?
|
Leisure Activities | 1 | 2005 | 311 | 0.060 |
Why?
|
Sunlight | 1 | 2005 | 324 | 0.060 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2013 | 1338 | 0.060 |
Why?
|
Double-Blind Method | 1 | 2017 | 11985 | 0.060 |
Why?
|
Geography | 1 | 2005 | 672 | 0.060 |
Why?
|
Microsurgery | 1 | 2008 | 793 | 0.050 |
Why?
|
Occupational Diseases | 1 | 2010 | 1474 | 0.050 |
Why?
|
Cataract | 1 | 2008 | 825 | 0.050 |
Why?
|
Risk Factors | 6 | 2011 | 71974 | 0.050 |
Why?
|
Time Factors | 3 | 2016 | 40050 | 0.040 |
Why?
|
Incidence | 4 | 2021 | 20913 | 0.040 |
Why?
|
Disease Progression | 2 | 2018 | 13237 | 0.040 |
Why?
|
Antiviral Agents | 1 | 2010 | 2971 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2014 | 19811 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2020 | 1585 | 0.030 |
Why?
|
Chronic Disease | 1 | 2011 | 9133 | 0.030 |
Why?
|
Odds Ratio | 2 | 2006 | 9846 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8605 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2011 | 21694 | 0.030 |
Why?
|
Placebos | 1 | 2020 | 1678 | 0.030 |
Why?
|
Occupational Exposure | 1 | 2005 | 1791 | 0.030 |
Why?
|
Glucocorticoids | 2 | 2014 | 2100 | 0.030 |
Why?
|
Arm | 1 | 2015 | 585 | 0.030 |
Why?
|
Indocyanine Green | 1 | 2013 | 239 | 0.030 |
Why?
|
Retreatment | 1 | 2013 | 603 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3453 | 0.030 |
Why?
|
Anesthesia, Local | 1 | 2013 | 265 | 0.020 |
Why?
|
Microscopy, Acoustic | 1 | 2011 | 45 | 0.020 |
Why?
|
Prevalence | 1 | 2008 | 15153 | 0.020 |
Why?
|
Coloring Agents | 1 | 2013 | 564 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2005 | 4220 | 0.020 |
Why?
|
Gonioscopy | 1 | 2011 | 157 | 0.020 |
Why?
|
Prospective Studies | 2 | 2013 | 53037 | 0.020 |
Why?
|
Costs and Cost Analysis | 2 | 2013 | 1675 | 0.020 |
Why?
|
Ciliary Body | 1 | 2011 | 173 | 0.020 |
Why?
|
Sclera | 1 | 2011 | 202 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2009 | 5632 | 0.020 |
Why?
|
Eicosapentaenoic Acid | 1 | 2013 | 581 | 0.020 |
Why?
|
Aptamers, Nucleotide | 1 | 2010 | 166 | 0.020 |
Why?
|
Fluorocarbons | 1 | 2013 | 443 | 0.020 |
Why?
|
Drug Resistance | 1 | 2013 | 1610 | 0.020 |
Why?
|
Iodine Radioisotopes | 1 | 2010 | 1031 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10362 | 0.020 |
Why?
|
Docosahexaenoic Acids | 1 | 2013 | 873 | 0.020 |
Why?
|
Suture Techniques | 1 | 2011 | 793 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2008 | 15194 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2010 | 1637 | 0.020 |
Why?
|
Administration, Oral | 1 | 2013 | 3909 | 0.020 |
Why?
|
United States | 3 | 2021 | 69573 | 0.020 |
Why?
|
Matched-Pair Analysis | 1 | 2004 | 289 | 0.010 |
Why?
|
Functional Laterality | 1 | 2010 | 2291 | 0.010 |
Why?
|
Brachytherapy | 1 | 2010 | 1247 | 0.010 |
Why?
|
Surgical Flaps | 1 | 2011 | 1627 | 0.010 |
Why?
|
Epidemiologic Research Design | 1 | 2004 | 368 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 12948 | 0.010 |
Why?
|
Health Care Costs | 1 | 2013 | 3226 | 0.010 |
Why?
|
Pilot Projects | 1 | 2013 | 8275 | 0.010 |
Why?
|
Siblings | 1 | 2004 | 853 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2010 | 6478 | 0.010 |
Why?
|
Cohort Studies | 2 | 2016 | 40389 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2006 | 1778 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 28901 | 0.010 |
Why?
|
Aspirin | 1 | 2010 | 3268 | 0.010 |
Why?
|
Ultrasonography | 1 | 2010 | 5941 | 0.010 |
Why?
|
Pediatrics | 1 | 1971 | 3454 | 0.010 |
Why?
|
Educational Status | 1 | 2004 | 2514 | 0.010 |
Why?
|
Vitamins | 1 | 2004 | 1602 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2004 | 2116 | 0.010 |
Why?
|
Adolescent | 2 | 2017 | 85405 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2004 | 3945 | 0.010 |
Why?
|
Young Adult | 1 | 2017 | 56255 | 0.010 |
Why?
|
Sex Factors | 1 | 2004 | 10398 | 0.010 |
Why?
|
Professional Practice | 1 | 1971 | 327 | 0.010 |
Why?
|
Brain | 1 | 2015 | 26345 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 35326 | 0.000 |
Why?
|
Smoking | 1 | 2004 | 8960 | 0.000 |
Why?
|
Canada | 1 | 1971 | 2021 | 0.000 |
Why?
|
Body Mass Index | 1 | 2004 | 12655 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2004 | 11699 | 0.000 |
Why?
|
Education, Medical, Graduate | 1 | 1971 | 2275 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2004 | 15070 | 0.000 |
Why?
|
Quality of Health Care | 1 | 1971 | 4365 | 0.000 |
Why?
|
Physicians | 1 | 1971 | 4539 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1971 | 25470 | 0.000 |
Why?
|
Infant | 1 | 1971 | 34923 | 0.000 |
Why?
|
Child, Preschool | 1 | 1971 | 40802 | 0.000 |
Why?
|
Child | 1 | 1971 | 77033 | 0.000 |
Why?
|
Concepts
(233)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_